Canopy Partners, LLC Astrazeneca PLC Transaction History
Canopy Partners, LLC
- $215 Billion
- Q2 2024
A detailed history of Canopy Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Canopy Partners, LLC holds 5,759 shares of AZN stock, worth $411,365. This represents 0.21% of its overall portfolio holdings.
Number of Shares
5,759
Previous 4,763
20.91%
Holding current value
$411,365
Previous $323 Million
39.19%
% of portfolio
0.21%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,348Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.64 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.04 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.9 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.62 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.26 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...